Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32321
Title: Correcting Hypernatremia in Children.
Austin Authors: Didsbury, Madeleine;See, Emily J ;Cheng, Daryl R;Kausman, Joshua;Quinlan, Catherine
Affiliation: Department of Nephrology, The Royal Children's Hospital, Melbourne, Victoria, Australia.
Intensive Care
School of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
Department of General Medicine and EMR Team, The Royal Children's Hospital, Melbourne, Victoria, Australia
Murdoch Children's Research Institute, Melbourne, Victoria, Australia
Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia
Issue Date: 1-Mar-2023
Publication information: Clinical Journal of the American Society of Nephrology: CJASN 2023; 18(3)
Abstract: In children with hypernatremia, current clinical guidelines recommend a reduction in serum sodium of 0.5 mmol/L per hour or less to avoid complications of cerebral edema. However, no large-scale studies have been conducted in the pediatric setting to inform this recommendation. Therefore, this study aimed to report the association between the rate of correction of hypernatremia, neurological outcomes, and all-cause mortality in children. A retrospective cohort study was conducted from 2016 to 2019 at a quaternary pediatric center in Melbourne, Victoria, Australia. All children with at least one serum sodium level ≥150 mmol/L were identified through interrogation of the hospital's electronic medical record. Medical notes, neuroimaging reports, and electroencephalogram results were reviewed for evidence of seizures and/or cerebral edema. The peak serum sodium level was identified and correction rates over the first 24 hours and overall were calculated. Unadjusted and multivariable analyses were used to examine the association between the rate of sodium correction and neurological complications, the requirement for neurological investigation, and death. There were 402 episodes of hypernatremia among 358 children over the 3-year study period. Of these, 179 were community-acquired and 223 developed during admission. A total of 28 patients (7%) died during admission. Mortality was higher in children with hospital-acquired hypernatremia, as was the frequency of intensive care unit admission and hospital length of stay. Rapid correction (>0.5 mmol/L per hour) occurred in 200 children and was not associated with greater neurological investigation or mortality. Length of stay was longer in children who received slow correction (<0.5 mmol/L per hour). Our study did not find any evidence that rapid sodium correction was associated with greater neurological investigation, cerebral edema, seizures, or mortality; however, slow correction was associated with a longer hospital length of stay.
URI: https://ahro.austin.org.au/austinjspui/handle/1/32321
DOI: 10.2215/CJN.0000000000000077
ORCID: 0000-0001-6150-7735
0000-0003-2746-6903
Journal: Clinical Journal of the American Society of Nephrology : CJASN
Start page: 306
End page: 314
PubMed URL: 36888887
ISSN: 1555-905X
Type: Journal Article
Subjects: Hypernatremia/etiology
Hypernatremia/therapy
Seizures/complications
Appears in Collections:Journal articles

Show full item record

Page view(s)

38
checked on Nov 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.